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Key points
 Our understanding of the mechanisms underlying the role of hypoxia in the initiation and
progression of renal disease remains rudimentary.
 We have developed a method that allows wireless measurement of renal tissue oxygen tension
in unrestrained rats.
 This method provides stable and continuous measurements of cortical tissue oxygen tension
(PO2) formore than 2weeks and can reproducibly detect acute changes in cortical oxygenation.
 Exogenous angiotensin-II reduced renal cortical tissue PO2 more than equi-pressor doses of
phenylephrine, probablybecause it reduced renal oxygendeliverymore thandidphenylephrine.
 Activation of the endogenous renin–angiotensin system in transgenicCyp1a1Ren2 rats reduced
cortical tissue PO2 ; in this model renal hypoxia precedes the development of structural
pathology and can be reversed acutely by an angiotensin-II receptor type 1 antagonist.
 Angiotensin-II promotes renal hypoxia, whichmay in turn contribute to its pathological effects
during development of chronic kidney disease.
Abstract We hypothesised that both exogenous and endogenous angiotensin-II (AngII) can
decrease the partial pressure of oxygen (PO2) in the renal cortex of unrestrained rats, whichmight
in turn contribute to the progression of chronic kidney disease. Rats were instrumented with
telemeters equipped with a carbon paste electrode for continuous measurement of renal cortical
tissue PO2 . The method reproducibly detected acute changes in cortical oxygenation induced
by systemic hyperoxia and hypoxia. In conscious rats, renal cortical PO2 was dose-dependently
reduced by intravenous AngII. Reductions in PO2 were significantly greater than those induced
by equi-pressor doses of phenylephrine. In anaesthetised rats, renal oxygen consumption was not
affected, and filtration fraction was increased only in the AngII infused animals. Oxygen delivery
decreased by 50% after infusion of AngII and renal blood flow (RBF) fell by 3.3 ml min−1.
Equi-pressor infusion of phenylephrine did not significantly reduce RBF or renal oxygen delivery.
Activation of the endogenous renin–angiotensin system in Cyp1a1Ren2 transgenic rats reduced
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cortical tissue PO2 . This could be reversed within minutes by pharmacological angiotensin-II
receptor type 1 (AT1R) blockade. Thus AngII is an important modulator of renal cortical
oxygenation via AT1 receptors. AngII had a greater influence on cortical oxygenation than did
phenylephrine. This phenomenon appears to be attributable to the profound impact of AngII on
renal oxygen delivery. We conclude that the ability of AngII to promote renal cortical hypoxia
may contribute to its influence on initiation and progression of chronic kidney disease.
(Received 6 April 2016; accepted after revision 8 July 2016; first published online 18 July 2016)
Corresponding author M. P. Koeners: School of Physiology & Pharmacology, University of Bristol, Bristol BS8 1TD,
UK. Email: m.koeners@bristol.ac.uk
Abbreviations AngII, angiotensin-II; AT1R, angiotensin-II receptor type 1; CKD, chronic kidney disease; CV,
coefficient of variation; DO2 , renal oxygen delivery; GFR, glomerular filtration rate; I3C, indole-3-carbinol; PE,
phenylephrine; PO2 , tissue oxygen tension; RAS, renin–angiotensin system; RBF, renal blood flow; QO2 , renal oxygen
consumption; TNa, tubular sodium reabsorption.
Introduction
Chronic kidney disease (CKD) is associated with low
tissue oxygen tension (PO2) within the kidney (i.e. renal
hypoxia) (Evans et al. 2013). For example, in rats renal
tissue hypoxia (i.e. PO2 < 10 mmHg) was detected
using pimonidazole adduct immunohistochemistry in the
remnant kidney model of CKD (Manotham et al. 2004).
Renal hypoxia has also been observed in the early stages
of glomerulonephritis in rats (Matsumoto et al. 2004).
These and other observations led to the proposition that
renal parenchymal hypoxia is not just a consequence of
kidney disease, but rather a critical pathological mediator,
irrespective of the primary aetiology of the disease (Fine
et al. 2000; Nangaku, 2006; Tanaka et al. 2006; Heyman
et al. 2008; Palm & Nordquist, 2011).
Activation of the renin–angiotensin system (RAS) is
an established modulator of the progression of CKD
(Remuzzi et al. 2005; Kobori et al. 2007). Angiotensin-II
(AngII) induces constriction of efferent arterioles causing
hypoperfusion of post-glomerular peritubular capillaries,
thus decreasing renal oxygen delivery (Calzavacca et al.
2015). Glomerular filtration rate (GFR) is usually
maintained under such conditions (Treeck et al. 2002),
so tubular sodium reabsorption, and thus renal oxygen
consumption, is little changed. Consistent with this
proposed mismatch between renal oxygen delivery and
consumption, cortical PO2 could be relatively low in
rats with AngII-dependent hypertension. Insufficient
availability of oxygen leads to cellular injury and loss of
function (Mimura & Nangaku, 2010). Therefore AngII
type 1 receptor (AT1R) blockade could be an inter-
esting therapy for hypoxia. Accordingly, RAS inhibition
has been found to improve cortical tissue oxygenation
in anaesthetised rats both with (Welch et al. 2003;
Manotham et al. 2004; Eckardt et al. 2005) and without
(Norman et al. 2003) kidney disease. Although these
studies were performed in an acute setting in animals
under anaesthesia, their findings suggest that AngII can
chronically have a negative impact on renal cortical
oxygenation, which could potentially be a critical factor
in the initiation and progression of CKD. Consistent with
this concept, angiotensin-converting enzyme inhibitors
and AT1R blockade are still used as first-line treatment
in patients with CKD who do not require dialysis, and
have been shown to improve survival (Qin et al. 2016).
The current understanding of the mechanisms under-
lying physiological regulation of kidney oxygenation, and
the contribution of renal tissue hypoxia in the initiation
and progression of renal disease, remains rudimentary
(Evans et al. 2015). Recently we developed a technology
that allows continuous and long-term measurement of
tissue PO2 in the kidney in unrestrained, conscious rats
(Koeners et al. 2013). This allows investigation of renal
oxygenation with high temporal resolution and without
the confounding effects inducedby anaesthesia. In the pre-
sent study we utilised this technique to test the hypothesis
that both exogenous and endogenousAngII promote renal
hypoxia.
The specific aims of our current study were fourfold.
In a first set of studies, we validated the use of telemetric
measurementof renal corticalPO2 formore than2weeks in
unrestrained rats and studied its physiological variation as
well as its ability to respond to repeated periods of hypoxia
and hyperoxia. In the second set of studies, in conscious
rats, we compared acute responses of cortical PO2 to
equi-pressor doses (I.V. boluses and infusions) of AngII
and the α1-adrenoceptor agonist phenylephrine (PE). In
the third set of studies, in anaesthetised rats, we examined
the mechanisms underlying the differential sensitivity of
renal cortical PO2 to AngII and PE, by also assessing their
effects on renal oxygen delivery and consumption. In the
fourth set of studies we determined in a cross-over design
whether prolonged activation (1 week) of endogenous
renin could lead to renal cortical hypoxia in a rat model
(the Cyp1A1Ren2 rat). This model is known to develop
inducible AngII-dependent hypertension and ultimately
CKD when renin activation is prolonged for 4 weeks or
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more (Heijnen et al. 2011, 2013, 2014). We determined
whether renal cortical hypoxia is an early event in this
process and whether it can be reversed by AT1R blockade
(Heijnen et al. 2013).
Methods
Ethical approval
All experiments were performed under license from the
Animal Ethics Committee of University of Auckland
(AEC R955) or the institutional Animal Care and Use
Committee of Maastricht University (DEC2014-012) and
were all carried out according to the guidelines laid down
by the New Zealand and Dutch Codes of Practice for
the Care and Use of Animals for Scientific Purposes and
complied with the policy and regulations of The Journal of
Physiology (Grundy, 2015).
System overview
The telemetry system, previously described by Russell
et al. (2012), was adapted for renal tissue (Koeners et al.
2013, 2016). Briefly, the telemeter (TR57Y, Millar Inc.,
Houston, TX, USA) was equipped with a carbon paste
electrode (CPE, 0.27mm in diameter) for electrochemical
detection of PO2 . This CPE electrode was implanted in
the rat kidney cortex, so that the tip of the electrode
was approximately 2 mm below the cortical surface.
Reference and auxiliary electrodes, made of silver wire
(AG549511; Advent Research Materials, Suffolk, UK),
were also implanted in the kidney. This maintained a
potentiostat circuit with a potential of -650 mV on the
CPE. The telemeter was placed in the abdomen of the rat
and attached to the inner abdominal muscle layer. After
a recovery period of 1 week, the rat’s cage was placed on
a receiver-charging unit (SmartPad TR181, Millar Inc.),
which received the data from, and recharged the battery
of, the telemeter. This setup allowed renal cortical tissue
PO2 to be measured continuously for several weeks at a
frequency of 400 Hz (Wistar rats) or 5 Hz (Cyp1a1Ren2
rats).
Animals
A total of 40 male Wistar rats (352 ± 13 g) and 8 male
Cyp1A1Ren2 rats (377 ± 28 g) were used. Wistar rats
were obtained from an internal breeding stock at the
University of Auckland, originally derived from Charles
River (USA). Cyp1A1Ren2 rats were obtained from an
internal breeding stock atMaastrichtUniversity, originally
derived from animals supplied by the Centre for Cardio-
vascular Science, University of Edinburgh, UK. These
rats harbour a genetically inserted construct for the
transcription of mRen2 preceded by a Cyp1a1 promoter
on the Y-chromosome. Cyp1a1 can be induced by adding
an aryl hydrocarbon agonist, such as indole-3-carbinol
(I3C), to the diet. This leads to an increase in (pro)renin
levels and subsequently a blood pressure increase (Heijnen
et al. 2013). All animals were housedwith a 12 h light–dark
cycle at a temperature of 20–22°C and allowed free
access to water and standard rat chow ad libitum. In
Cyp1A1Ren2 rats, I3C was mixed through the diet to
achieve concentrations of 0.3 or 0.6% w/w (Heijnen et al.
2013). This diet was administered to activate the RAS in
these transgenic rats. After the experimental period, all
rats were killed by intraperitoneal injection of an over-
dose of sodium pentobarbitone (>200 mg ml−1, Provet
NZ PTY Ltd, Auckland, NZ) and postmortem PO2 values
were determined for off-set correction of individual PO2
recordings.
Validation of the system in the rat kidney cortex
Surgery/implantation. Telemeters were prepared and
surgery was performed as previously described (Koeners
et al. 2013, 2016). In summary, telemeters were sterilised
in a 2% w/v glutaraldehyde solution for at least 4 h and
rinsed thoroughly with sterile 0.9% w/v NaCl solution
before implantation. Male Wistar rats (n = 15) were
anaesthetised with 5% v/v isoflurane in an induction box
and maintained at 2–2.5% v/v isoflurane via a mask on
a heated operating table. Rats were pre-medicated with
enrofloxacin (5 μg kg−1 S.C., Baytrill, SVS Vet Supplies
Ltd, Auckland, NZ) and buprenorphine (30 μg kg−1 S.C.,
Temgesic, Reckitt Benckiser, Auckland, NZ, or ASTfarma
B.V., Ouderwater, Netherlands). Under sterile conditions,
the left kidney and aorta were exposed by laparotomy.
The cables connecting the electrodes and telemeter were
secured by suturing them on the adventitia of the
abdominal aorta or dorsal muscles adjacent to the spine
near the left kidney. After pre-puncturing the kidney
with a 30 gauge needle, the reference electrode and
CPE, both with a right-angled bend 2 mm from the
tip, were inserted in the kidney cortex and secured in
place with tissue glue (Histoacryl, 1050044 B. Braun,
Tuttlingen, Germany) approximately 1 mm apart from
each other, while the auxiliary electrode was affixed onto
the kidney surface. With the telemeter placed and secured
in the abdomen, the abdomen was closed with sutures
and the rat was placed on a heated pad for at least
12 h to recover. Post-operative analgesia was administered
(buprenorphine, 3 μg (100 g−1) every 8–14 h for up to
3 days or as required).
Cortical PO2 by CPE-telemetry for 19 days. Renal cortical
PO2 was continuously measured in nine Wistar rats for
19 days. The coefficient of variation (CV) of the PO2 signal
was assessed in each rat over the last 14 days (days 6–19)
for each recording. CV was calculated in percentage as
(standard deviation (individual means for a specific time
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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interval))/(allmeans for a specific time interval). The three
specific time intervals we used were: days 6–19, 24 h, and
5 min. Kidneys were processed for assessment of tissue
damage and scarring around the implanted electrode tip
by Masson’s trichrome staining. As found previously in
the renal medulla (Koeners et al. 2013), there was little or
no scarring associated with implantation of the electrodes
in the cortex (Fig. 1).
Responses to altered inspired oxygen content. During
the 19 days after implantation of the telemeter, Wistar
rats underwent repetitive hypoxia/hyperoxia trials to
determine the reproducibility of responses of the system
to changes in cortical tissue PO2 . Details of this protocol
were described previously (Koeners et al. 2013). Briefly,
at 3–4 day intervals the rat’s home cage was placed in a
custom-made Perspex chamber (65 cm x 45 cm x 35 cm)
which was filled with hypoxic air (10% oxygen) or hyper-
oxic air (100%oxygen) for 30min periods (5 lmin−1). The
O2 concentration in the sealed box was measured using a
gas analyser (ADInstruments). The PO2 during the final
5 min of each trial was compared with that recorded while
rats breathed room air (21% oxygen). Hypoxic and hyper-
oxic conditions were presented in random order and each
challenge was preceded and followed by a 30 min period
in which the rat was exposed to room air.
Effects of angiotensin II and phenylephrine on renal
cortical oxygen tension
Conscious rats. MaleWistar rats (n= 7, 333± 15 g) were
instrumented with CPE-telemeters as described above.
100 µm
Figure 1. Representative section of the renal cortex, 3 weeks
after implantation of the electrode, stained with Masson’s
trichrome
Fibrotic tissue is represented by blue, the nuclei by dark purple, and
other cellular compartments by red. Electrode diameter and position
are indicated by a green circle. Photomicrograph at ×10
magnification.
Another group ofmaleWistar rats (n= 6, 339± 11 g) was
instrumented with blood pressure telemeters (TRM56SP,
Millar Inc.) and a blood pressure catheter was introduced
and fixed into the abdominal aorta as described previously
(Lau et al. 2013). During the same surgical procedure both
groups were equipped with a catheter placed in the left
femoral vein. This catheter was tunnelled subcutaneously
so that it exited between the shoulder blades. The catheters
were made of heparin coated tubing (Micro-Renathane
model MRE 33 connected to model MRE 40 tubes, 3 cm
and 16 cm in length, respectively). Following surgery, a
5 day recovery period was allowed before experimental
manipulations commenced. Stable recordingwas achieved
when within-animal coefficient of variation (CV) of the
PO2 signal over 24 h was less than 31 ± 6% for 2 days.
During the AngII (Auspep Pty Ltd, Victoria, Australia)
and PE (Sigma, USA) intervention, rats were placed in a
custom-made Perspex chamber (25 cm x 45 cm x 35 cm)
and acclimatised for 30 min while their femoral vein
catheter was connected to tubing leading out of the
box. Baseline PO2 was defined as the average during the
final 10 min of this period. To avoid acute (seconds)
desensitisation to AngII (Guo et al. 2001), I.V. bolus
injections (5 μg ml−1 kg–1) were given at 0, 5, 10, 15,
and 30 s, in volumes of 1, 2, 7, 20, and 70 μl, in order to
give cumulative doses of 5, 15, 50, 150, and 500 ng kg–1,
respectively. Averages of the last 2 s before the next step
were used to calculate PO2 and mean arterial pressure
(MAP). The dose range was chosen based on previous
experience (Nelissen-Vrancken et al. 1992). On the same
day, after a 60–120 min recovery period, bolus doses of
PE of 20, 200, 500, 1000 and 1500 ng kg–1 were injected
in volumes of 100 μl at 5 min intervals. These doses were
chosen to produce similar changes inMAP as those evoked
byAngII. Averages from30 to 40 s after the boluswere used
to calculate PO2 . The entire protocol was repeated 2–3 days
later, except that the order of the treatments was reversed
(i.e. PE was administered before AngII).
Subsequently, responses to 10 min infusions of AngII
(150 ng min−1 kg–1, the second highest dose given in the
bolus injection) and PE (7.2 μg min −1 kg–1, chosen to
produce similar changes inMAPas those evoked byAngII)
were determined. The PO2 and MAP were averaged over
the final 60 s of each infusion. This protocol was repeated
in a reverse order (i.e. PE first, then AngII) 2–3 days later.
Anaesthetised rats. In terminal experiments, MAP and
RBF (transit-time ultrasound) were determined in male
Wistar rats (n = 25, 361 ± 11 g) as described previously
(Koeners et al. 2007). Briefly, all rats were anaesthetised
with 5% v/v isoflurane, intubated and then artificially
ventilated (model 680;HarvardApparatus,Holliston,MA,
USA) with 2–2.5% v/v isoflurane in 100% O2 and a tidal
volume of3–4 ml and frequency of70 breaths min−1.
Catheters were placed in the jugular and femoral veins
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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for infusions. The femoral artery was catheterised to
measure MAP and collect blood. The left ureter and
bladder were cannulated in order to collect urine. The
infusion solution contained inulin to calculate GFR
by inulin clearance as described previously (Racasan
et al. 2003). The sodium content of urine and plasma
samples was determined by flame photometry (IL 543,
Instrument Laboratory, Lexington, MA, USA). Cortical
PO2 was determined using the telemeter and electrodes,
implanted acutely, as described previously (Koeners et al.
2013). During the control period, urine was collected
over two 10 min periods and arterial blood samples
(0.2–0.3 ml) were collected before and after the entire
20 min period. After these control clearance periods,
an intravenous infusion of either saline (n = 9), AngII
(100–140 ng min –1 kg–1, n = 8) or PE (3.8 μg min −1
kg–1, n = 8) commenced. Once arterial blood pressure
and cortical PO2 had stabilised at the new level, urine and
blood were collected over two 10 min clearance periods.
Arterial (via femoral catheter) and renal venous blood
(via renal vein) samples were then obtained for oximetry
at the end of the experiment (i.e. during infusion of
saline, AngII or PE). Blood oxygen content (O2ct) was
calculated as O2ct = ([haemoglobin (g l−1)] × oxygen
saturation × 1.34) + (blood PO2 × 0.003). Renal oxygen
delivery (DO2) was calculated as the product of RBF
and arterial O2ct, while renal oxygen consumption (QO2)
was calculated as the product of RBF and the difference
between arterial and renal venous blood oxygen content
(Papazova et al. 2015).
Sub-acute activation of the endogenous renin–
angiotensin system. Male transgenic Cyp1a1Ren2 rats
(n = 8) were instrumented with CPE-telemeters in the
renal cortex as described above. In a cross-over design,
after a 7 day recovery period, four rats were exposed to
a 0.3% w/w I3C (Sigma-Aldrich, St Louis, MO, USA)
containing diet for 1 week. The genetic construct in these
animals, which is activated by I3C, dose-dependently
stimulates hepatic production of mouse renin (Mullins
et al. 1990) and causes AngII-dependent glomerular
sclerosis, tubular atrophy, and renal parenchymal
inflammation after 4 weeks, accompanied by hyper-
tension (Kantachuvesiri et al. 2001; Heijnen et al. 2013).
The other four rats remained on the normal (control)
diet. During the second week, diets were switched
between groups. In week 4 both groups were fed a 0.6%
w/w I3C containing diet. After 2–4 days of 0.6% I3C
feeding, rats received a subcutaneous injection of the
angiotensin receptor antagonist losartan (MSD, Oss,
the Netherlands, 30 mg kg−1, n = 7). Cortical PO2
was recorded continuously during the experiment. To
determine the effect of the diets, all data were averaged
over 3 h epochs. Baseline PO2 (= 100%) was set as
the group average PO2 value calculated over 6 h before
commencing the dietary intervention. To isolate the
effects of AT1R blockade, data were averaged for 5 min
periods and a new baseline (= 100%) was calculated
as the group average PO2 value over 15 min before
injection. Baseline PO2 was calculated from the group PO2
averages, instead of the individual PO2 averages, in order
to demonstrate the between-animal/probe variation.
Analysis of PO2 data. Raw PO2 data were filtered with a
25 Hz low-pass filter (data fromWistar rats) and artifacts
were removed when the 1st order derivative exceeded a
threshold of 5–300 nA s−1 (Wistar and Cyp1a1Ren2 rats),
as described previously (Koeners et al. 2013).
All PO2 data are expressed as relative values from
individual baseline recordings unless stated otherwise.
Statistical analysis
Data are expressed as means ± SEM. They were subjected
to Levene’s mean test (to test equality of variance) and
repeated measures analysis of variance (ANOVA), or one-
or two-way ANOVA. To protect against increased risk of
type 1 error arising from the use of multiple comparisons,
either Tukey’s test (when all possible comparisons were
made) or Dunnett’s test (when multiple treatments were
compared to a control condition) was applied. Statistics
were performedusing SigmaPlot software (Systat Software
Inc, California, CA, USA). Differences were considered
statistically significant if two-sided P  0.05 and are pre-
sented as unequal lower case letters within the figures.
Results
Validation of chronic telemetric measurement
of tissue PO2 in the rat kidney cortex
Renal cortical tissue PO2 was labile during the first 5 days
after implantation, but thereafter remained relatively
stable for the 14 day observation period (Fig. 2A). To
quantify the stability of the PO2 signal, the average
within-animal CV of the PO2 signal was calculated over
three specific time intervals (days 6–19, 24 h and 5 min)
over the entire period of the last 14 days (n = 9). The
averagemeanCVderived fromdays 6–19was 22.5± 3.8%,
that from the 24 h interval was 21.8± 2.1% and that from
the 5 min interval was 5.1 ± 0.3%.
The responsiveness and reproducibility of telemetric
recordings of cortical PO2 were tested in vivo by hypo-
xia/hyperoxia trials (Fig. 2B). In all trials (4 trials in each
of 9 animals) hyperoxia substantially increased cortical
PO2 , by 132 ± 31% with a mean CV derived from a 1 min
time interval of 4.6± 0.8%. Cortical PO2 decreased during
hypoxia in all trials, with a mean reduction of 57 ± 9%
and a mean CV derived from a 1 min time interval of
5.9 ± 1.6%.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Effects of exogenous angiotensin II and
phenylephrine on cortical oxygenation
Acute vasoconstrictor-specific responses. In conscious
ratsAngII andPEwere administered as I.V. bolus injections
titrated to result in pressor responses of similarmagnitude,
as assessed by telemetric measurement of arterial pressure
(Fig. 3A). Renal cortical PO2 was reduced by both PE and
AngII (Fig. 3B). At higher doses, the effects of AngII on
PO2 in the renal cortex were greater than those of PE. For
example, a dose of 500 ng kg–1 AngII decreased PO2 by
54 ± 14%, whereas PO2 was decreased only by 21 ± 7%
at an equi-pressor dose of 1500 ng kg–1 PE. Responses of
MAP and cortical PO2 to AngII and PE developed within
seconds of the injection (Fig. 3C and D).
The differential effects of AngII and PE on cortical
oxygenation were more pronounced when these agents
were administered as short-term infusions than when
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Figure 2. Validation of long-term measurement of cortical
tissue PO2
A, mean daily cortical tissue PO2 over a 19 day period, expressed as a
percentage of the average values on days 6–19 across all rats
(n = 9). B, mean change in cortical tissue PO2 in response to
hyperoxia (filled bars) and hypoxia (open bars) in all rats (n = 9),
compared to baseline values assessed during normoxia (room air,
21% oxygen). I–IV represent the successive trials performed at
3–4 day intervals. Data are expressed as between-rat means ± SEM.
administered as boluses. Cortical PO2 fell by 41 ± 5%
during an infusion of AngII at a dose of 150 ngmin−1 kg–1
but was not significantly altered by PE at a dose of
7.2 μg min −1 kg–1, (−2 ± 6% change) (Fig. 4B). These
infusions of AngII and PE resulted in similar increases
in MAP (Fig. 4A). Infusion of AngII caused a prolonged
effect, which was normalised only when the infusion was
stopped. Original tracings during AngII and PE infusion
in a representative rat are shown in Fig. 4C and D.
Effects of exogenous angiotensin II and
phenylephrine on renal blood flow
and oxygenation in anaesthetised rats
In anaesthetised rats, cortical PO2 decreased by 21 ± 5%
during infusion of AngII. PE infusion did not change
cortical PO2 significantly−9± 10% change, Fig. 5C). The
two infusions resulted in similar increases inMAP(Table 1,
Fig. 5A). However, themagnitude of the change in cortical
PO2 associatedwith infusion of AngII and PE did not differ
significantly. RBF decreased more (3.3 ± 0.3 ml min−1)
during infusion of AngII than during infusion of PE
(1.5± 0.4mlmin−1, Fig. 5B). Infusion of the saline vehicle
resulted in little or no change in cortical PO2 , MAP or
RBF.
Compared to rats receiving an infusion of the saline
vehicle, renal oxygen delivery was significantly more
reduced (50 ± 4%) in rats receiving AngII than in rats
receiving PE (10 ± 5%, P < 0.05, Fig. 5D). However, the
othermeasures of whole kidney oxygenation, renal oxygen
consumption (Fig. 5E) and fractional extraction (Fig. 5F)
did not differ significantly between rats treatedwith saline,
AngII, or PE. GFR was not significantly altered during any
infusion (Fig. 5G). However, filtration fraction increased
by39±10%during infusionofAngII (Fig. 5H) but didnot
change significantly during infusion of saline or PE. No
significant differences in the ratio between tubular sodium
reabsorption andQO2 (TNa/QO2) were found between the
three treatment groups (Fig. 5I).
Effects of activation of the endogenous
renin–angiotensin system on cortical oxygenation
When 0.3% I3C was added to the food of the Cyp1a2Ren2
transgenic rats, renal cortical PO2 gradually fell over the
subsequent 30 h. A nadir was reached 25 ± 4 h after the
presentation of the diet (Fig. 6A) with cortical PO2 being
20 ± 6% below its baseline value. During the challenge
with 0.6% I3C the nadir in cortical PO2 , a reduction of
29 ± 9% below baseline, was observed 23 ± 10 h after the
presentation of the diet (Fig. 6B).
Blockade of the AT1R in Cyp1a1Ren2 transgenic rats
fed 0.6% I3C resulted in a rapid increase of cortical
PO2 . Peak responses were reached 14 ± 3 min after S.C.
administrationof losartan,where corticalPO2 was37±7%
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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higher than before injection (Fig. 6D). Original tracings
to illustrate the dynamics of the responses to the I3C diet
and losartan are shown in Fig. 6C and 6E.
Discussion
The results of this study show that, in conscious
unrestrained rats, renal cortical oxygen tension is
decreased by stimulation of the AT1R by both exogenous
and endogenous AngII. Using devices for telemetric
measurement of tissue PO2 , we show for the first time in
conscious unrestrained rats that acute renal cortical hypo-
xia induced by exogenous AngII is (1) greater than that
evoked by equi-pressor doses of phenylephrine; and (2) is
mainly caused by reduced RBF rather than by increased
oxygen consumption. We also show that relative renal
cortical hypoxia (3)occurs relatively fast (within24h) after
activation of endogenous AngII, well before histological
manifestation of renal disease, and (4) can be rapidly
(within minutes) reversed by an AT1 receptor antagonist.
These new data are consistent with the hypothesis that
AngII-induced renal cortical hypoxia is a causal factor in
the aetiology of renal disease rather than a consequence of
other pathological processes.
Validation of chronic telemetric measurement
of tissue PO2 in the renal cortex
The ability to assess renal tissue PO2 in unrestrained rats
over prolonged periods provides a new tool to investigate
the role of renal tissue hypoxia in the pathogenesis of
kidney disease. Previously, we demonstrated that the
device utilised in the current study can be employed to
assess tissue oxygenation in the renal medulla of the rat
(Koeners et al. 2013). Now we extend these studies by
demonstrating that this method is also applicable in the
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Figure 3. Responses of arterial pressure and cortical tissue PO2 to intravenous boluses of angiotensin-II
and phenylephrine in conscious rats
A, peak mean arterial pressure during intravenous (I.V.) bolus injections of increasing doses of angiotensin-II (AngII,
filled bars) and phenylephrine (PE, open bars) titrated to produce equi-pressor effects (n = 6). B, mean changes
of cortical PO2 in response to I.V. injections of the same increasing doses of AngII (filled bars) and PE (open bars)
in a separate cohort of rats (n = 7). C and D, original individual tracings of mean arterial pressure and cortical
PO2 , respectively, during I.V. injection of AngII and PE, recorded in a representative rat. Data in panels A and B are
shown as means ± SEM. Data were subjected to RM ANOVA (equal variance test: A, passed, P = 0,742; B, passed,
P = 0,223) followed by Tukey’s post hoc test. Differences were considered statistically significant if two-tailed
P  0.05(∗).
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renal cortex. We validated the methodology by showing
thatmeasurements of corticalPO2 were stable over aperiod
of 6–19 days after implantation of the CPE telemeter.
Long- and short-term coefficients of variation were 22%
and 5%. These are comparable to those reported for blood
pressure or heart rate in rats (Teerlink&Clozel, 1993; Jiang
et al. 2016). Secondly we showed that the method could
reproducibly detect acute changes in cortical oxygenation
induced by systemic hyperoxia and hypoxia. Variations to
these repeated challenges were as low as 5–6%. These data
demonstrate that the technique is able to reproducibly
detect changes in renal tissue oxygenation induced by
systemic challenges. This provides strong evidence that
the system is reliable for long-term monitoring of renal
cortical oxygenation in the rat.
Effects of exogenous angiotensin II
and phenylephrine on cortical oxygenation
in conscious rats
We then used this method to assess the influence of
exogenous AngII on cortical PO2 . Cortical tissue PO2 was
reduced immediately by intravenous administration of
AngII. We can be confident that the reduction in cortical
PO2 induced by AngII is not a consequence of its pre-
ssor effect, because equi-pressor doses of PE had a much
lower effect on tissue PO2 , irrespective of whether the
agents were administered as boluses or infusions. It seems
likely that the differential effects of AngII and PE on renal
oxygenation reflect their disparate actions at the level of
the renal vasculature.
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Effects of exogenous angiotensin II
and phenylephrine on renal blood flow
and oxygenation in anaesthetised rats
The rapidity with which cortical tissue PO2 fell in response
to administration of AngII, either as a bolus or infusion,
supports the idea that this effect is driven predominantly
by the impact of AngII on RBF (Polichnowski et al.
2013), and thus renal oxygen delivery, rather than on
kidney oxygen consumption (Friederich-Persson et al.
2014). Indeed it is well known that AngII decreases renal
blood flow (Hollenberg et al. 1976; Yamamoto et al.
2001; Kobori et al. 2007). To verify this, we performed
studies in anaesthetised rats in which we could quantify
renal oxygenation and haemodynamics. AngII reduced
cortical PO2 , RBF and DO2 more than PE did. We
could not detect effects of AngII or PE on QO2 , renal
fractional oxygen extraction or TNa/QO2 . The present
data contrast with those from a study by Welch et al.
in which a decreased TNa/QO2 was observed. However,
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Figure 5. Responses to intravenous infusions of angiotensin-II and phenylephrine in anaesthetised rats
Responses of mean arterial pressure (A) and renal blood flow (B) before (black bar) infusion or after (grey bar) 10min
intravenous infusions, and changes in cortical tissue PO2 (C) after infusions of saline (Sal, n = 9), angiotensin-II
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Sal (n = 7), AngII (n = 7) and PE (n = 5). Data shown as means ± SEM and subjected to two (A, B, G, H)- or one
(C, D, E, F, I)-way ANOVA followed by Tukey’s post hoc test. Differences were considered statistically significant if
two-tailed P  0.05(∗).
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Table 1. Haemodynamic parameters before and during vasoconstrictor infusions in anaesthetised rats
Baseline Saline Baseline AngII Baseline PE
n 9 7 7
MAP (mmHg) 83 ± 2 84 ± 3 83 ± 3 111 ± 3∗# 84 ± 2 119 ± 3∗#
RBF (ml min–1) 6.7 ± 0.4 6.8 ± 0.5 7.0 ± 0.6 3.7 ± 0.3∗# 8.2 ± 0.7 6.7 ± 0.4∗
Cortical PO2 (%) — 2.2 ± 4.0 — −21.0 ± 5.1# — −8.8 ± 9.8
FF 0.33 ± 0.02 0.31 ± 0.02 0.35 ± 0.01 0.49± 0.03∗# 0.41 ± 0.03 0.44 ± 0.03
Data are expressed as means ± SEM. Data were subjected to one-way (Cortical PO2 ) or two-way (MAP, RBF, FF) ANOVA followed by
Tukey’s post hoc test. Differences were considered statistically significant if two-tailed P  0.05. ∗Significant difference versus baseline
within the same group; #significant difference versus post-infusion of saline. MAP = mean arterial pressure; RBF = renal blood flow;
FF = filtration fraction.
the latter studies were done after prolonged (2 week)
infusion of AngII (Welch et al. 2005). Critically, long-term
effects of this potent peptide might be quite different
from those evoked by the short-term bolus injections
or 10 min infusions that we used. Hence, in the pre-
sent study, the more pronounced reduction in cortical
PO2 in response to AngII compared to PE is likely to be
due to their differential effects on oxygen delivery to the
renal cortex. In awake sheep, AngII did not significantly
alter renal cortical PO2 when RBF and renal oxygen
consumption were reduced by 21% and 18%, respectively
(Calzavacca et al. 2015). Similar results were observed in
anaesthetised rabbits (Evans et al. 2011). Thus, it appears
that a threshold in the reduction in RBF (>30%) must
be exceeded before cortical hypoxia occurs. In addition,
total RBF and DO2 do not take into account regional
variations in blood flow, oxygen delivery/consumption,
and potentially also changes in counter-current shunting
of oxygen (Evans et al. 2008). Together this probably
explains why PE did not significantly reduce cortical
PO2 . Furthermore, renal resistance was reduced and RBF
increased after a non-hypotensive dose of captopril in
healthy conscious rats (Nelissen-Vrancken et al. 1992),
suggesting, although not decisively, that RAS inhibition
could increase renal tissue PO2 by increasing DO2 . The
maintenance of Q˙O2 during infusion of AngII is probably
due to the maintenance of GFR (as reflected in increased
FF), and thus the filtered load of sodium. Consistent with
this proposition, van der Bel et al recently showed a strong
association of reduced cortical oxygenation (as assessed
by blood oxygen level-dependent magnetic resonance
imaging) with increased filtration fraction during intra-
venous infusion of angiotensin II inman (van der Bel et al.
2016).
Differences between the systemic and renal effects
of AngII and PE were greater in conscious than in
anaesthetised animals. Potentially, in conscious animals,
the ability of AngII to act presynaptically to facilitate
sympathetic neurotransmission (Nap et al. 2002) could be
greater than that in anaesthetised animals. Isoflurane and
other inhalation anaesthetics tend to inhibit the activity
of the sympathetic nervous system (Pac-Soo et al. 2000).
They can also blunt the response of the vasculature to
AngII and increase the sensitivity of the vasculature to
α-adrenoceptor activation (Yu et al. 2004; Bussey et al.
2014). These considerations emphasise the importance
of avoiding the confounding effects of anaesthesia in
studies of the physiological control of renal oxygenation.
Hence, a definitive conclusion regarding the relative roles
of changes in oxygen delivery versus oxygen consumption
in AngII-induced cortical hypoxia can only be made by
simultaneous in vivo measurement of these variables in
conscious animals. This is not (yet) possible in rats.
Activation of the endogenous renin–angiotensin
system on cortical oxygenation
Activation of the endogenous renin–angiotensin system
reduced cortical PO2 . The time course of the effect in
conscious Cyp1a1Ren2 transgenic rats was consistent with
previous studies in this model that have documented
activation of the RAS. For example, arterial pressure
was found to have increased by approximately 12 h
after administration of I3C by gastric gavage, while
pro-renin levels were found to have increased within
6 h (Kantachuvesiri et al. 2001). In the current study we
found a statistically significant decrease in PO2 after 15 h
of dietary exposure to I3C. The slower time course of
effects in our study can be attributable to the fact that I3C
was delivered via the food rather than by gastric gavage.
The immediate reversal of hypoxia by AT1R blockade
indicates that the effects of I3C feedingoncorticalPO2 were
mediated directly through activation of AT1 receptors and
exclude other components of the RAS (e.g. aldosterone).
This is in line with the findings of Norman et al., who
observed increased cortical PO2 coinciding with increased
RBF and microvascular flow after acute AT1R blockade
in healthy (anaesthetised) rats (Norman et al. 2003).
Prolonged activation of the RAS in Cyp1a1Ren2 rats
causes hypertension, increased renal vascular resistance
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 6. Effects of activation of the endogenous renin–angiotensin system
Mean cortical tissue PO2 is expressed as a percentage of the average values during the 6 h before commencing
feeding with a diet containing either 0.3%w/w (A, n= 8) or 0.6%w/w (B, n= 7) indole-3-carbinol (I3C). Grey lines
represent data for individual rats, while the thick black line represents the between-rat mean. C, original tracing,
obtained with 5 Hz sample frequency, of the current recorded in a representative rat, before and during feeding
with 0.6% I3C (expressed as nA). The dashed line indicates commencement of the I3C diet. CPE, carbon paste
electrode. Data was subjected to RM ANOVA (equal variance test: A, passed, P = 0,130; B, passed, P = 0,901)
followed by Dunnett’s post hoc test. Differences were considered statistically significant if two-tailed P 0.05(∗) vs.
baseline. Effects of blockade of the endogenous renin–angiotensin system. D, mean cortical tissue PO2 before and
after subcutaneous injection of losartan during feeding with 0.6% w/w indole-3-carbinol (I3C). PO2 is expressed
as a percentage of the average values during the 10 min period prior to injection of losartan. Grey lines represent
data for individual rats, while the thick black line represents the between-rat means. E, original tracing, obtained
with 5 Hz sample frequency, of the current recorded in a representative rat, expressed as nA, before and after
subcutaneous injection of losartan. The dashed line indicates the moment of losartan injection. CPE, carbon paste
electrode. Data were subjected to RM ANOVA (equal variance test: A, passed, P = 0,163) followed by Dunnett’s
post hoc test. Differences were considered statistically significant if two-tailed P  0.05(∗) vs. baseline.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
12 T. W. Emans and others J Physiol 000.00
(as measured by flow probe), glomerulosclerosis and
tubulointerstitial inflammation (Heijnen et al. 2011,
2013). In addition, in Cyp1a1Ren2 rats, the kidney seems
to be more at risk of development of injury than the
heart, which showed only relatively mild maladaptation
(i.e. mild and reversible myocardial concentric hyper-
trophic remodelling) despite the fulminant hypertension
(Heijnen et al. 2014). Our current findings indicate that
renal hypoxia in this model is likely to be driven by
renal vasoconstriction, and precedes development of overt
renal pathology, which is not observed until 4 weeks after
initiation of I3C treatment (Kantachuvesiri et al. 2001;
Heijnen et al. 2013). Thus, renal hypoxia is more likely to
be a stimulus that contributes to the pathological process
rather than just a consequence of pathology.
To the best of our knowledge, our findings are the first to
provide direct evidence that endogenous AngII can reduce
cortical tissuePO2 in conscious, unrestrained rats, through
activation of AT1R. Our findings are consistent with those
of others, of the effects of AT1R blockade in anaesthetised
rats (Norman et al. 2003; Manotham et al. 2004). These
findings pave the way for detailed investigation of the
temporal relationships between renal cortical hypoxia and
renal pathology in chronic kidneydisease and acute kidney
injury.
Three important limitations of our study must be
acknowledged. Firstly, we are unable to measure tissue
PO2 in more than one place using our current telemetric
approach. This precludes us from characterising the
spatial relationships between tissue hypoxia and renal
pathology using this method. Secondly, we are unable
to quantify renal oxygen delivery and consumption in
un-anaesthetised rats. Thus, we had no alternative than
to measure these variables in groups of anaesthetised
and ventilated rats. Nevertheless, the responses of cortical
tissue PO2 to AngII in anaesthetised rats were similar to
those in conscious rats. Thus, we can be confident that
our observations in rats under anaesthesia are relevant
to the interpretation of our studies in conscious animals.
Thirdly, as discussed previously (Koeners et al. 2013) we
remain cautious about using absolute PO2 values due to
discrepancies between the calibration parameters before
versus calibration after implantation, and the presence of
an additional zero offset under in vivo conditions. We
consequently used relative values in our analysis instead
of absolute concentration. This offset places restraints
on study design, because it makes direct between-animal
comparisons problematic. However, it does not limit
the use of within-animal experimental designs in which
changes in PO2 are determined from a baseline established
before the intervention, as was done in this study.
In conclusion, our current findings indicate that it is
feasible to investigate tissue oxygenation in the renal cortex
by telemetry. We found that exogenous AngII rapidly and
markedly reduced cortical PO2 in conscious rats. Our
data suggest that the effect is mainly due to decreased
tissue oxygen delivery as a consequence of cortical
vasoconstriction and reduced RBF. Activation of the end-
ogenous RAS in the Cyp1a1Ren2 transgenic rat resulted
in reduced cortical tissue PO2 which was rapidly reversed
by AT1R blockade. Thus, both exogenous and endogenous
AngII can induce renal cortical hypoxia.
It has been proposed that renal tissue hypoxia is a final
common pathway in the pathogenesis of chronic kidney
disease (Fine et al. 2000;Nangaku, 2006; Tanaka et al. 2006;
Heyman et al. 2008; Palm&Nordquist, 2011). To critically
test this hypothesis, we require methods to continuously
monitor renal tissue oxygenation in unrestrained animals,
so we can elucidate the temporal relationships between
renal pathology and renal tissue hypoxia in models of
chronic kidney disease such as the Cyp1a1Ren2 rat. Our
current findings indicate that telemetric methods are
appropriate and valid for this purpose.
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